Alambic Investment Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-10,037
Closed -$488K – 294
2019
Q4
$488K Sell
10,037
-6,100
-38% -$278K 0.41% 91
2019
Q3
$767K Buy
16,137
+2,800
+21% +$132K 0.58% 51
2019
Q2
$573K Sell
13,337
-1,300
-9% -$50.5K 0.35% 111
2019
Q1
$566K Sell
14,637
-7,922
-35% -$269K 0.23% 157
2018
Q4
$643K Buy
22,559
+8,922
+65% +$283K 0.27% 138
2018
Q3
$534K Sell
13,637
-3,415
-20% -$126K 0.42% 84
2018
Q2
$551K Sell
17,052
-6,600
-28% -$182K 0.15% 201
2018
Q1
$519K Buy
23,652
+6,667
+39% +$160K 0.07% 310
2017
Q4
$402K Sell
16,985
-3,915
-19% -$98.7K 0.05% 345
2017
Q3
$588K Buy
+20,900
New +$636K 0.06% 329

Other funds holding CSII

Alambic Investment Management's CSII Position: Q1 2020 in Review

Alambic Investment Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2020, closing a stake of 10,037 shares — an estimated $488K sold.

Alambic Investment Management first reported a position in CSII in Q3 2017 and held it in 10 quarters. The position peaked at $767K in Q3 2019. 183 funds tracked by Wall St. Rank hold CSII as of Q1 2020.

  • Alambic Investment Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2020 after selling out during the quarter.
  • Alambic Investment Management sold 10,037 Cardiovascular Systems, Inc. shares in Q1 2020, an estimated $488K.
  • Alambic Investment Management first reported a position in Cardiovascular Systems, Inc. in Q3 2017 and held it in 10 quarters.
  • Alambic Investment Management's Cardiovascular Systems, Inc. position peaked at $767K in Q3 2019.
  • 183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2020.

Based on Alambic Investment Management's 13F filing for Q1 2020, filed 11 May 2020.